Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
4554:TYO
Fuji Pharma Co Ltd
¥2,242.00
+0.76%
(+17.00) 1D
Apr 28, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4554...
Open
¥2,229
High
¥2,242
Low
¥2,169
Mkt. cap
59.51B
Avg. vol.
104.00K
Volume
149.50K
Dividend
1.90%
Quarterly dividend
¥11
Ex dividend date
Mar 30, 2026
P/E ratio
23.49
52-wk high
¥2,559
52-wk low
¥1,233
EPS
¥95
Shares outstanding
29.92M
No. of employees
2K
News stories
From sources across the web
About Fuji Pharma Co Ltd
CEO-
Employees1.76K
FoundedApr 1, 1965
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.10B
12.86B
14.72B
15.90B
Cost of goods sold
6.51B
8.00B
8.71B
9.08B
Cost of revenue
6.51B
8.00B
8.71B
9.08B
Research and development expenses
-
-
3.34B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.53B
3.80B
-428.00M
4.03B
Operating expense
3.53B
3.80B
4.39B
4.03B
Total operating expenses
10.04B
11.80B
13.10B
13.11B
Operating income
1.05B
1.06B
1.62B
2.79B
Other non operating income
79.00M
-45.00M
68.00M
-47.00M
EBT including unusual items
379.00M
946.00M
1.30B
195.00M
EBT excluding unusual items
1.02B
909.00M
1.63B
2.65B
Income tax expense
83.00M
403.00M
133.00M
-129.00M
Effective tax rate
21.90%
-
10.21%
-66.15%
Other operating expenses
-
-
-
-
Net income
296.00M
543.00M
1.17B
324.00M
Net profit margin
2.67%
-
7.95%
2.04%
Earnings per share
-
-
-
-
Interest and investment income
3.00M
4.00M
-
-
Interest expense
-66.00M
-95.00M
-100.00M
-84.00M
Net interest expenses
-63.00M
-91.00M
-100.00M
-84.00M
Depreciation and amortization charges
-
-
1.38B
-
EBITDA
2.05B
1.98B
2.61B
3.78B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more